Is mTOR Inhibitor Good Enough for Treatment All Tumors in TSC Patients?

Tuberous sclerosis complex (TSC) is an autosomal dominant and multi-system genetic disorder in humans. TSC affects around 25,000 to 40,000 individuals in the United States and about 1 to 2 million individuals worldwide, with an estimated prevalence of one in 6,000 newborns. TSC occurs in all races a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Cancer
Main Authors: Habib, Samy L, Al-Obaidi, Noor Y, Nowacki, Maciej, Pietkun, Katarzyna, Zegarska, Barbara, Kloskowski, Tomasz, Zegarski, Wojciech, Drewa, Tomasz, Medina, Edward A., Zhao, Zhenze, Liang, Sitai
Formato: Artigo
Idioma:Inglês
Publicado em: Ivyspring International Publisher 2016
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5039383/
https://ncbi.nlm.nih.gov/pubmed/27698899
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.14747
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados